Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Phitsanu Raksakulkarn"'
Autor:
Somboon Tansuphasawasdikul, Ploenchan Chetchotisakd, Jintanat Anaworanich, Phitsanu Raksakulkarn, Wisit Prasithsirikul, Sasisopin Kiertiburanakul, Kiat Ruxrungtham, Warangkana Munsakul, Sineenart Chautrakarn, Bernard Hirschel, Reto Nüesch, Angèle Gayet-Ageron
Publikováno v:
The Open AIDS Journal, Vol. 3 (2009) pp. 38-45
The Open AIDS Journal
The Open AIDS Journal
Objective:Investigation on anxiety, stress, depression, and quality of life (QoL) within STACCATO, a randomised trial of two treatment strategies: CD4 guided scheduled treatment interruption (STI) compared to continuous treatment (CT).Participants:Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0aeb46f5c5819899098d02f27ddb973
https://doi.org/10.2174/1874613600903010038
https://doi.org/10.2174/1874613600903010038
Autor:
Ploenchan Chetchotisakd, Reto Nüesch, Claudette S. Satchell, David A. Cooper, Warangkana Munsakul, Kiat Ruxrungtham, Michelle Le Braz, Enos Bernasconi, Daniel Genné, Jintanat Ananworanich, Phitsanu Raksakulkarn, Sabine Yerly, Praphan Phanuphak, Urs Karrer, Matthias Cavassini, Dominic Leduc, Sunee Sirivichayakul, Andrew Hill, Wisit Prasithsirikul, Angèle Gayet-Ageron, Bernard Hirschel, Hansjakob Furrer, Sasisopin Kiertiburanakul, Thomas V. Perneger, Somboon Tansuphasawasdikul, Luc Perrin, Pietro Vernazza
Publikováno v:
The Lancet, Vol. 368, No 9534 (2006) pp. 459-465
Lancet, 368(9534), 459-465. Elsevier Limited
Lancet, 368(9534), 459-465. Elsevier Limited
BACKGROUND: Stopping antiretroviral therapy in patients with HIV-1 infection can reduce costs and side-effects, but carries the risk of increased immune suppression and emergence of resistance. METHODS: 430 patients with CD4-positive T-lymphocyte (CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4730eee4a10a5ffd3297ba75baf6565
https://doi.org/10.1016/s0140-6736(06)69153-8
https://doi.org/10.1016/s0140-6736(06)69153-8
Autor:
Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604
https://doi.org/10.1177/135965350501000604
Autor:
Sasisopin Kiertiburanakul, Jintanat Ananworanich, Ploenchan Chetchotisakd, Phitsanu Raksakulkarn, Wisit Prasithsirikul, Sasiwimol Ubolyam, Bernard Hirschel, Somboon Tansuphasawadikul, Kiat Ruxrungtham, Warangkana Munsakul, Wendy Snowden, Malte Schutz, Sunee Sirivichayakul, Thidarat Jupimai
Publikováno v:
Antiviral therapy, 11(5), 631-635. International Medical Press Ltd
Antiviral Therapy, Vol. 11, No 5 (2006) pp. 631-635
Antiviral Therapy, Vol. 11, No 5 (2006) pp. 631-635
BackgroundThere are few data on the selection of resistance by ritonavir-boosted saquinavir (SQV/r), particularly in antiretroviral (ARV)-naive patients.ObjectiveTo assess the incidence of virological failure and evolution of resistance in ARV-naive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30001415b04b180aa5d6c23007966a5
https://pure.amc.nl/en/publications/absence-of-resistance-mutations-in-antiretroviralnaive-patients-treated-with-ritonavirboosted-saquinavir(937332ee-c397-4b29-b5b0-a014a2da870f).html
https://pure.amc.nl/en/publications/absence-of-resistance-mutations-in-antiretroviralnaive-patients-treated-with-ritonavirboosted-saquinavir(937332ee-c397-4b29-b5b0-a014a2da870f).html
